Board of Directors

Paul Badawi

Founder & Chief Executive Officer

Paul Badawi is a Founder and Chief Executive Officer of Sight Sciences, Inc. He is a co-inventor of the OMNI™ Surgical System, VISCO360® Viscosurgical System, TRAB®360 Trabeculotomy System, Helix™ Microstent, and TearCare®.

David Badawi, MD

Founder & Chief Technology Officer

Dr. David Badawi is a Founder and Chief Technology Officer of Sight Sciences, Inc. He is a co-inventor of the OMNI™ Surgical System, VISCO360® Viscosurgical System, TRAB®360 Trabeculotomy System, Helix™Microstent, and TearCare®. David leads the company’s application and development of technology towards the treatment of the underlying causes of ophthalmic disease. He also oversees the preclinical and clinical development of each of the company’s products.

Staffan Encrantz

Allegro Investment Fund, L.P.

Staffan Encrantz is the founder and Chairman of Allegro Investment Fund, L.P., a registered Cayman Islands Investment Fund that is managed by Allegro Investment Inc. Located in Menlo Park, CA, Allegro primarily invests in growth stage private companies and supports its portfolio by providing growth capital as well as strategic, operating and financial expertise.

Mack Hicks

Hicks Holdings, LLC

Mack Hicks is currently a Partner of Hicks Holdings, LLC, and has been with the firm since 2007. In addition to his involvement with Hicks Holdings, he served as the Managing Partner of Hicks Cedar Park LLC from 2008 to 2014, which owned and operated the Cedar Park Center and the Texas Stars AHL hockey franchise. Mr. Hicks is also Co-Founder of, an Internet marketing company focused on online golf instruction.

Carter Meyer

Scientific Health Development

Carter Meyer has been the Chief Executive Officer of Scientific Health Development (SHD) since its formation in February 2006, and is a general partner of its newest fund. Located in Dallas, Texas, SHD is an investment fund focused on earlier-stage life science companies. Prior to joining SHD, Mr. Meyer was an attorney in private practice for more than 12 years, most recently with the Dallas office of Vinson & Elkins L.L.P.

Valeska Schroeder

KCK Medical Technologies

Valeska has been a Managing Director of KCK’s Medical Technologies Investment Group since 2016. KCK is a single-family fund investing in a range of industries in private equity, growth capital, and venture capital, including a focus of growth equity investments in medical technology companies. Valeska is a board member for KCK portfolio companies, including Sight Sciences, Cerapedics, Intuity Medical, and Aerin Medical and is a board observer for Reflexion Medical. Before joining KCK, Valeska held roles in product development, program management, and marketing in medical device companies, including VitalConnect, Acclarent, and NDC.

Erica Rogers

Silk Road Medical

Erica Rogers, President and CEO of Silk Road Medical (NASDAQ: SILK), is an experienced leader and entrepreneur in the medical device industry. She most recently led Silk Road Medical through FDA approval of its groundbreaking TCAR devices for the treatment of carotid artery disease, commercial scale-up and initial public offering. Prior to her role at Silk Road Medical, Ms. Rogers was the Chief Operating Officer of Medicines360, a non-profit pharmaceutical company developing drugs and devices for women. She was previously the founder and CEO of Allux Medical, as well as the co-founder of Visiogen, an ophthalmic medical device company acquired by Abbott Medical Optics in 2009. In addition, Ms. Rogers is an advisor to Alydia Health, a company developing solutions for postpartum hemorrhage, and to Venture Investors, one of the leading healthcare venture capital firms based in the mid-western United States.